Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology- United States

doi 10.1016/j.jaci.2018.12.313

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical Therapeutics
Pharmacology
2016English

Favorable Clinical Efficacy of Mepolizumab on the Upper and Lower Airways in Severe Eosinophilic Asthma: A 48-Week Pilot Study

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2019English

Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Patients With Severe Eosinophilic Asthma Treated With Mepolizumab: Results From Our Clinical Practice

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Assessment of the Long-Term Safety of Mepolizumab and Durability of Clinical Response in Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Mepolizumab for Severe Refractory Eosinophilic Asthma: Evidence to Date and Clinical Potential

Therapeutic Advances in Chronic Disease
Medicine
2016English

Severe Eosinophilic Asthma and Aspirin-Exacerbated Respiratory Disease Associated to Eosinophilic Gastroenteritis Treated With Mepolizumab: A Case Report

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2020English

Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy